Cargando…
Pluronics-Based Drug Delivery Systems for Flavonoids Anticancer Treatment
This research concerns the investigation of the preparation of polymeric nanocarriers containing a flavonoid—naringenin, xanthohumol or isoxanthohumol—based on Pluronics by the thin-film formation method. The size of the formed micelles and their stability upon dilution were evaluated using Dynamic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957264/ https://www.ncbi.nlm.nih.gov/pubmed/36826313 http://dx.doi.org/10.3390/gels9020143 |
_version_ | 1784894782993072128 |
---|---|
author | Ronka, Sylwia Kowalczyk, Aleksandra Baczyńska, Dagmara Żołnierczyk, Anna K. |
author_facet | Ronka, Sylwia Kowalczyk, Aleksandra Baczyńska, Dagmara Żołnierczyk, Anna K. |
author_sort | Ronka, Sylwia |
collection | PubMed |
description | This research concerns the investigation of the preparation of polymeric nanocarriers containing a flavonoid—naringenin, xanthohumol or isoxanthohumol—based on Pluronics by the thin-film formation method. The size of the formed micelles and their stability upon dilution were evaluated using Dynamic light scattering (DLS) analysis; the high values of the drug loading and the encapsulation efficiency confirmed that the proposed systems of flavonoids delivery consisting of Pluronic P123 and F127 nanomicelles could effectively distribute the drug into tumour tissues, which makes these nanocarriers ideal candidates for passive targeting of cancer cells by the enhanced permeation and retention (EPR) effect. The in vitro cytotoxicity of proposed flavonoids in the Pluronic formulations was investigated by the SRB assay with human colon cancer cells. We designed mixed polymeric micelles, which was a successful drug delivery system for the case of naringenin not being able to enhance the bioavailability and cytotoxic activity of xanthohumol and isoxanthohumol. Furthermore, it was observed that the higher amount of polymer in the formulation achieved better cytotoxic activity. |
format | Online Article Text |
id | pubmed-9957264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99572642023-02-25 Pluronics-Based Drug Delivery Systems for Flavonoids Anticancer Treatment Ronka, Sylwia Kowalczyk, Aleksandra Baczyńska, Dagmara Żołnierczyk, Anna K. Gels Article This research concerns the investigation of the preparation of polymeric nanocarriers containing a flavonoid—naringenin, xanthohumol or isoxanthohumol—based on Pluronics by the thin-film formation method. The size of the formed micelles and their stability upon dilution were evaluated using Dynamic light scattering (DLS) analysis; the high values of the drug loading and the encapsulation efficiency confirmed that the proposed systems of flavonoids delivery consisting of Pluronic P123 and F127 nanomicelles could effectively distribute the drug into tumour tissues, which makes these nanocarriers ideal candidates for passive targeting of cancer cells by the enhanced permeation and retention (EPR) effect. The in vitro cytotoxicity of proposed flavonoids in the Pluronic formulations was investigated by the SRB assay with human colon cancer cells. We designed mixed polymeric micelles, which was a successful drug delivery system for the case of naringenin not being able to enhance the bioavailability and cytotoxic activity of xanthohumol and isoxanthohumol. Furthermore, it was observed that the higher amount of polymer in the formulation achieved better cytotoxic activity. MDPI 2023-02-08 /pmc/articles/PMC9957264/ /pubmed/36826313 http://dx.doi.org/10.3390/gels9020143 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ronka, Sylwia Kowalczyk, Aleksandra Baczyńska, Dagmara Żołnierczyk, Anna K. Pluronics-Based Drug Delivery Systems for Flavonoids Anticancer Treatment |
title | Pluronics-Based Drug Delivery Systems for Flavonoids Anticancer Treatment |
title_full | Pluronics-Based Drug Delivery Systems for Flavonoids Anticancer Treatment |
title_fullStr | Pluronics-Based Drug Delivery Systems for Flavonoids Anticancer Treatment |
title_full_unstemmed | Pluronics-Based Drug Delivery Systems for Flavonoids Anticancer Treatment |
title_short | Pluronics-Based Drug Delivery Systems for Flavonoids Anticancer Treatment |
title_sort | pluronics-based drug delivery systems for flavonoids anticancer treatment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957264/ https://www.ncbi.nlm.nih.gov/pubmed/36826313 http://dx.doi.org/10.3390/gels9020143 |
work_keys_str_mv | AT ronkasylwia pluronicsbaseddrugdeliverysystemsforflavonoidsanticancertreatment AT kowalczykaleksandra pluronicsbaseddrugdeliverysystemsforflavonoidsanticancertreatment AT baczynskadagmara pluronicsbaseddrugdeliverysystemsforflavonoidsanticancertreatment AT zołnierczykannak pluronicsbaseddrugdeliverysystemsforflavonoidsanticancertreatment |